UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

Diabetes care, 2018-08, Vol.41 (8), p.1681-1688

2018

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

Endocrine practice, 2016-02, Vol.22 (2), p.231-262

2016

Volltextzugriff (PDF)

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

Diabetes technology & therapeutics, 2019-05, Vol.21 (5), p.231-237

2019

Volltextzugriff (PDF)

Needle Technology for Insulin Administration: A Century of Innovation

Journal of Diabetes Science and Technology, 2023-03, Vol.17 (2), p.449-457

2023

Volltextzugriff (PDF)

Evaluation of a Predictive Low-Glucose Management System In-Clinic

Diabetes technology & therapeutics, 2017-05, Vol.19 (5), p.288-292

2017

Volltextzugriff (PDF)

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor

Diabetes technology & therapeutics, 2014-05, Vol.16 (5), p.277-283

2014

Volltextzugriff (PDF)

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study

Diabetes technology & therapeutics, 2012-03, Vol.14 (3), p.205-209

2012

Volltextzugriff (PDF)

Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm

Journal of diabetes science and technology, 2015-03, Vol.9 (2), p.209-214

2015

Volltextzugriff (PDF)

Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations

Diabetes technology & therapeutics, 2021-09, Vol.23 (S3), p.S5-S-11

2021

Volltextzugriff (PDF)

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-04, Vol.325 (14), p.1403

2021

Volltextzugriff (PDF)

Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors

Diabetes technology & therapeutics, 2017-05, Vol.19 (S2), p.S51-S-54

Bailey, Timothy S

2017

Volltextzugriff (PDF)

The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed ™ 670G Hybrid Closed-Loop System

Diabetes technology & therapeutics, 2017-12, Vol.19 (12), p.749-752

2017

Volltextzugriff (PDF)

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-07, Vol.318 (1), p.33

2017

Volltextzugriff (PDF)

Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study

Endocrinology, diabetes & metabolism, 2022-01, Vol.5 (1), p.e00306-n/a

2022

Volltextzugriff (PDF)

Response to Letter to the Editor (DOI: 10.1089/dia.2019.0343)

Diabetes technology & therapeutics, 2020-03, Vol.22 (3), p.241-241

Bailey, Timothy S

2020

Volltextzugriff (PDF)

Clinical Efficacy of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes

The Journal of family practice, 2018-06, Vol.67 (6), p.S14

Bailey, Timothy S

2018

Volltextzugriff (PDF)

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Diabetes care, 2017-04, Vol.40 (4), p.554-560

2017

Volltextzugriff (PDF)

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Diabetes technology & therapeutics, 2017-03, Vol.19 (3), p.155-163

2017

Volltextzugriff (PDF)

Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analogues

Diabetes/metabolism research and reviews, 2020-10, Vol.36 (7), p.e3329-n/a

2020

Volltextzugriff (PDF)

Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time

Journal of Diabetes Science and Technology, 2023-07, Vol.17 (4), p.1066-1076

2023

Volltextzugriff (PDF)

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

Diabetes technology & therapeutics, 2022-06, Vol.24 (6), p.373-380

2022

Volltextzugriff (PDF)

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Diabetes technology & therapeutics, 2019-01, Vol.21 (1), p.11-19

2019

Volltextzugriff (PDF)

Synthesis and X-ray structural studies of a substituted 2,3,4,5-tetrahydro-1H-3-benzazonine and a 1,2,3,5-tetrahydro-4,3-benzoxazonine

Molecules (Basel, Switzerland), 2014-12, Vol.20 (1), p.487-502

2014

Volltextzugriff (PDF)

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Endocrine practice, 2015-04, Vol.21 Suppl 1, p.1-87

2015

Volltextzugriff (PDF)

Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review

Diabetic medicine, 2024-07, Vol.41 (7), p.e15339-n/a

2024

Volltextzugriff (PDF)

1 – 25 von 1.574

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.407)
Mit Volltextzugriff
(1.296)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.571)
Arabisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(977)
Life Sciences & Biomedicine
(810)
Humans
(566)
Male
(309)
Female
(294)
Animals
(214)
Biological And Medical Sciences
(185)
Middle Aged
(173)
Adult
(165)
Physical Sciences
(144)
Medical Sciences
(130)
Aged
(121)
Biochemistry & Molecular Biology
(111)
Technology
(108)
Endocrinology & Metabolism
(99)
Diabetes
(98)
Mice
(90)
General & Internal Medicine
(73)
Insulin
(73)
Fundamental And Applied Biological Sciences. Psychology
(70)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(19)

Menü

Weitere Dienste

Einstellungen

Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2016 OUTPATIENT GLUCOSE MONITORING CONSENSUS STATEMENT

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

Needle Technology for Insulin Administration: A Century of Innovation

Evaluation of a Predictive Low-Glucose Management System In-Clinic

Accuracy and acceptability of the 6-day Enlite continuous subcutaneous glucose sensor

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study

Clinical Accuracy of a Continuous Glucose Monitoring System With an Advanced Algorithm

Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations

Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial

Clinical Implications of Accuracy Measurements of Continuous Glucose Sensors

The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed ™ 670G Hybrid Closed-Loop System

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial

Clinical outcomes in high‐hypoglycaemia‐risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first‐generation basal insulin analogue in the United States : Results from the DELIVER High Risk real‐world study

Response to Letter to the Editor (DOI: 10.1089/dia.2019.0343)

Clinical Efficacy of Once-weekly Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes

Comparison of Insulin Glargine 300 Units/mL and 100 Units/mL in Adults With Type 1 Diabetes: Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Insulin glargine 300 U/mL and insulin degludec: A review of the current evidence comparing these two second‐generation basal insulin analogues

Insulin Titration Guidelines for Patients With Type 1 Diabetes: It Is About Time

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes

Synthesis and X-ray structural studies of a substituted 2,3,4,5-tetrahydro-1H-3-benzazonine and a 1,2,3,5-tetrahydro-4,3-benzoxazonine

American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015

Frequency of hypoglycaemia with basal insulin treatments in adults with type 1 diabetes treated with basal‐bolus insulin regimens in treat‐to‐target trials: A narrative review

Suchergebnisse filtern